USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta

Details for Australian Patent Application No. 2003302070 (hide)

Owner GALDERMA RESEARCH AND DEVELOPMENT, S.N.C.

Inventors MICHEL, Serge; JOMARD, Andre; DEMARCHEZ, Michel; MAUVIEL, Alain; PENDARIES, Valerie

Pub. Number AU-A-2003302070

PCT Number PCT/EP2003/0148

PCT Pub. Number WO2004/045595

Priority 02/14319 15.11.02 FR; 60/430,671 04.12.02 US

Filing date 14 November 2003

Wipo publication date 15 June 2004

International Classifications

A61K 031/192

Event Publications

8 July 2004 Complete Application Filed

  Priority application(s): 02/14319 15.11.02 FR; 60/430,671 04.12.02 US

15 July 2004 Application Open to Public Inspection

  Published as AU-A-2003302070

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302071-PHLEBOTOMY DEVICE

2003302069-METHOD FOR DETERMINING OPTIMAL REACTION PROCESSES AND OPTIMAL OPERATING CONDITIONS FOR SYNTHESIS OF CHEMICAL COMPOUNDS IN MICRO-REACTION INSTALLATIONS